105
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Molybdenum Target X-Ray Features and Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 in Invasive Breast Cancer

, , &
Pages 2777-2783 | Published online: 23 Jun 2021

References

  • Liu JL. Breast cancer is the most common cancer worldwide for the first time. Chin J Breast Dis. 2020;14(06):389.
  • Lialiaris TS, Kouskoukis A, Georgiou G, et al. Expression of 6 common antigenic markers in invasive ductal breast carcinoma: potential clinical implications. Appl Immunohistochem Mol Morphol. 2011;19(2):106–111. doi:10.1097/PAI.0b013e3181e181b1
  • Yan J, Liu XL, Han LZ, et al. Relation between Ki-67, ER, PR, Her2/neu, p21, EGFR, and TOP II-α expression in invasive ductal breast cancer patients and correlations with prognosis. Asian Pac J Cancer Prev. 2015;16(2):823–829. doi:10.7314/APJCP.2015.16.2.823
  • Hu C, Liu J, Zhao Y, Liu P. Study on the relationship of tumor projection position and body surface positioning by mammography conventional position. J Pract Radiol. 2013;29(10):1662–1665.
  • Breast Cancer Professional Committee of Chinese Anti-Cancer Association. Chinese anti-cancer association guidelines and specifications for diagnosis and treatment of breast cancer (2019 edition). Chin Oncol. 2019;29(08):609–680.
  • Magny SJ, Shikhman R, Keppke AL. Breast, imaging, reporting and data system (BI RADS). In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2020.
  • DeSantis C, Ma J, Bryan L, Jemal A. Breast cancer statistics, 2013. CA Cancer J Clin. 2014;64(1):52–62. doi:10.3322/caac.21203
  • Zhai C, Zheng J, Peng W. Advances in imaging studies of triple-negative breast cancer. Mod Pract Med. 2018;30(05):565–567.
  • Rong X, Kang Y, Wu Z, Zhang L, Gu T, Wu Y. Comparison of full digital X-ray findings and clinicopathological features of breast cancer in the elderly and young people. Chin J Gerontol. 2018;38(07):1664–1665.
  • Hwang SH, Park DJ, Jee YS, et al. Risk factors for operative complications in elderly patients during laparoscopy-assisted gastrectomy. J Am Coll Surg. 2009;208(2):186–192. doi:10.1016/j.jamcollsurg.2008.10.023
  • Liu X, Lin Q, Cui C, Jiang Z, Bian T. Correlation analysis of HER-2 and mammographic features of breast cancers with ER and PR in the same expression condition. J Clin Radiol. 2015;34(1):31–35.
  • Ivkovic-Kapicl T, Knezevic-Usaj S, Djilas-Ivanovic D, Panjkovic M. Correlation of HER-2/neu protein overexpression with other prognostic and predictive factors in invasive ductal breast cancer. In Vivo (Brooklyn). 2007;21(4):673–678.
  • Park H, Chang SK, Kim JY, Lee BM, Shin HS. Risk factors for distant metastasis as a primary site of treatment failure in early-stage breast cancer. Chonnam Med J. 2014;50(3):96–101. doi:10.4068/cmj.2014.50.3.96
  • Eriksson L, Czene K, Rosenberg L, Humphreys K, Hall P. Possible influence of mammographic density on local and locoregional recurrence of breast cancer. Breast Cancer Res. 2013;15(4):R56. doi:10.1186/bcr3450
  • Wang Y, Chen Z, Zhang D, Zhou H, Cao X, Wang X, Effect of the primary tumor location on the prognosis of breast invasive ductal carcinoma patients treated with radical mastectomy. Chin J Oncol. 2019;(09):686–692. doi:10.3760/cma.j.issn.0253-3766.2019.09.008
  • Zhuang L, Wang H, Song F, Wang X. The diagnostic value of high frequency ultrasonography and molybdenum target imaging for early breast cancer. J Pract Radiol. 2017;33(007):1020–1023.
  • Lim ST, Choi JE, Kim SJ, et al. Prognostic implication of the tumor location according to molecular subtypes in axillary lymph node-positive invasive ductal cancer in a Korean population. Breast Cancer Res Treat. 2016;156(3):473–483. doi:10.1007/s10549-016-3771-6
  • Sun L, Yu DH, Sun SY, Zhuo SC, Cao SS, Wei L. Expressions of ER, PR, HER-2, COX-2, and VEGF in primary and relapsed/metastatic breast cancers. Cell Biochem Biophys. 2014;68(3):511–516. doi:10.1007/s12013-013-9729-y
  • Guan X, Yu L, Deng Q, Lin Y, Luo B. Correlation analysis of breast cancer contrast-enhanced ultrasound and its prognostic factors. Chin J Ultrasound Med. 2016;32(12):1069–1072.
  • Itoh M, Iwamoto T, Matsuoka J, et al. Estrogen receptor (ER) mRNA expression and molecular subtype distribution in ER-negative/progesterone receptor-positive breast cancers. Breast Cancer Res Treat. 2014;143(2):403–409. doi:10.1007/s10549-013-2763-z
  • Smeets A, Ryckx A, Belmans A, et al. Impact of tumor chronology and tumor biology on lymph node metastasis in breast cancer. Springerplus. 2013;23(2):480. doi:10.1186/2193-1801-2-480